Rapid Detection with Chikungunya IgG and IgM Test Kits
In today's fast-paced world, timely and accurate diagnosis of infectious diseases is paramount for effective treatment and control. QL Biotech takes pride in introducing a state-of-the-art solution for the swift detection of Chikungunya virus - our advanced Chikungunya IgG and IgM Rapid Test Device/strip. This innovative testing tool is designed to meet the urgent needs of healthcare professionals by providing a reliable, quick, and non-invasive method to ascertain exposure to the Chikungunya virus.
The essence of our Chikungunya IgG and IgM Rapid Test lies in its sophisticated, lateral flow immunoassay technology, which facilitates the qualitative detection of Chikungunya virus glycoproteins (IgG and IgM antibodies) in human serum, plasma, or whole blood samples. The presence of these antibodies indicates a recent or past infection, offering invaluable information for clinicians in the diagnosis and management of patients.
Employing a simple, yet powerful procedure, our test strip delivers results within 15 to 20 minutes, enabling healthcare providers to make informed decisions swiftly. Each kit is meticulously produced under stringent quality control measures, ensuring high sensitivity and specificity. This ensures that patients receive timely care, which is crucial in managing the symptoms and preventing the spread of the virus. The compact and user-friendly design of our Rapid Test Device/strip makes it an ideal choice for various settings, including clinics, hospitals, and field laboratories, facilitating widespread access to accurate Chikungunya virus screening. (QL Biotech's commitment to innovation and healthcare excellence is at the core of our product development. By integrating cutting-edge technologies with practical application, we strive to enhance the effectiveness of disease detection and contribute to the global fight against infectious diseases. Our Chikungunya IgG and IgM Rapid Test Device/strip is a testament to this commitment, offering a reliable, quick, and accessible solution for the detection of this increasingly common virus. With QL Biotech, healthcare professionals and patients alike can trust in the accuracy and reliability of their diagnostic tools, enabling better health outcomes and a safer, disease-free future.)
PRINCIPLE
The Strep A Rapid Test Device/strip is a qualitative, lateral flow immunoassay for the detection of Strep A carbohydrate antigen in a throat swab. In this test, antibody specific to Strep A carbohydrate antigen is coated on the test line region of the test. During testing, the extracted throat swab specimen reacts with an antibody to Strep A that is coated onto particles. The mixture migrates up the membrane to react with the antibody to Strep A on the membrane and generate a color line in the test line region. The presence of this color line in the test line region indicates a positive result, while its absence indicates a negative result. To serve as a procedural control, a colored line will always appear in the control line region, indicating that proper volume of specimen has been added and membrane wicking has occurred.
Product Detail
-
-
Brand:QL
Specimens: : Swab
Reading time：5 minutes.
Pack：20 T
STORAGE: 2‐30°C
KIT COMPONENTS(Device)
- •Test devices •Sterile swabs
- •Workstation • Strep A Reagent A (1M Sodium Nitrite )
- •Strep A Reagent B (0.4M Acetic Acid) • Test tubes
- •Dropper tips • Package insert
KIT COMPONENTS(strip)
- •Test strips • Sterile swabs
- •Workstation • Strep A Reagent A (1M Sodium Nitrite )
- •Strep A Reagent B (0.4M Acetic Acid) • Test tubes
- •Package insert
-
PROCEDURE
- Allow the test device, reagents, throat swab specimen, and/or controls to reach room temperature (15-30°C) prior to testing.
1. Remove the test device from the sealed foil pouch and use it as soon as possible.
Best results will be obtained if the test is performed immediately after opening the foil pouch.
2. Hold the Reagent A bottle vertically and add 4 full drops (approximately 240 µL) of Reagent A to an extraction test tube. Reagent A is red in color. Hold the
Reagent B bottle vertically and add 4 full drops (approximately 160 µL) to the tube. Reagent B is colorless. Mix the solution by gently swirling the extraction test tube. The addition of Reagent B to Reagent A changes the color of the solution from red to yellow.
3. Immediately add the throat swab to the extraction test tube of yellow solution. Agitate the swab 10 times in the tube. Leave the swab in the tube for 1 minute. Then press the swab against the side of the tube and squeeze the bottom of the tube as the swab is withdrawn. Discard the swab.
4. Fit the dropper tip on top of the extraction test tube. Place the test device on a clean and level surface. Add 3 full drops of solution (approx. 100 µL) to the specimen well (S) and then start the timer.
5. Wait for the colored line(s) to appear. Read the result at 5 minutes. Do not read the result after 10 minutes.
INTERPRETATION OF RESULTS
- NOTE:
- The intensity of the color in test region (T) may vary depending on the concentration of aimed substances present in the specimen. Therefore, any shade of color in the test region should be considered positive. Besides, the substances level can not be determined by this qualitative test.
- Insufficient specimen volume, incorrect operation procedure, or performing expired tests are the most likely reasons for control band failure.
Employing a simple, yet powerful procedure, our test strip delivers results within 15 to 20 minutes, enabling healthcare providers to make informed decisions swiftly. Each kit is meticulously produced under stringent quality control measures, ensuring high sensitivity and specificity. This ensures that patients receive timely care, which is crucial in managing the symptoms and preventing the spread of the virus. The compact and user-friendly design of our Rapid Test Device/strip makes it an ideal choice for various settings, including clinics, hospitals, and field laboratories, facilitating widespread access to accurate Chikungunya virus screening. (QL Biotech's commitment to innovation and healthcare excellence is at the core of our product development. By integrating cutting-edge technologies with practical application, we strive to enhance the effectiveness of disease detection and contribute to the global fight against infectious diseases. Our Chikungunya IgG and IgM Rapid Test Device/strip is a testament to this commitment, offering a reliable, quick, and accessible solution for the detection of this increasingly common virus. With QL Biotech, healthcare professionals and patients alike can trust in the accuracy and reliability of their diagnostic tools, enabling better health outcomes and a safer, disease-free future.)